Munafa Stock Market Course + Intraday & FNO calls 
Myriad Genetics (MYGN) Technical (Analysis) Reports Myriad Genetics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Myriad Genetics (MYGN)
Technical Analysis Report for USA stock MYGN Myriad Genetics. Dated: 26 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Biotechnology In Vitro In Vivo Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock MYGN Myriad Genetics then click here. or read Experts views on Myriad Genetics or Forecast & share price targets of Myriad Genetics
Myriad Genetics Opened at 6.53 and Closed at: 6.48, which is -1.08% of previous session's close. It moved within a range of 6.39 and 6.62
The session was a Bearish session with an average volume of 936400, which is 54.65% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
A Dead cross was found 8 days back on short term averages
Support for tomorrow is 6.32 and resistance for tomorrow is 6.55
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 6.37, 6.27 resistance for tomorrow's hourly charts is 6.6, 6.73
10 Day SMA for Myriad Genetics (MYGN) is 6.76 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Myriad Genetics (MYGN) is 7 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Myriad Genetics (MYGN) is 7.2 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 7.06 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Myriad Genetics is 6.6 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Myriad Genetics is at 7 and 200 DMA is at 6.6, while 50 DMA and 100 DMA are at 7.2 and 7.06 respectively
Myriad Genetics (MYGN) moving average of 20 SMA is at 7 and 20 EMA is at 6.9
| Date | Closing Price | 20 SMA | 20 EMA |
| 26 Fri Dec | 6.48 | 7 | 6.9 |
| 24 Wed Dec | 6.55 | 7.06 | 6.94 |
| 23 Tue Dec | 6.56 | 7.13 | 6.98 |
| 22 Mon Dec | 6.76 | 7.19 | 7.02 |
| 19 Fri Dec | 6.55 | 7.22 | 7.05 |
| 18 Thu Dec | 6.70 | 7.23 | 7.1 |
Myriad Genetics (MYGN) moving average of 50 SMA is at 7.2 and 50 EMA is at 7.04
| Date | Closing Price | 50 SMA | 50 EMA |
| 26 Fri Dec | 6.48 | 7.2 | 7.04 |
| 24 Wed Dec | 6.55 | 7.23 | 7.06 |
| 23 Tue Dec | 6.56 | 7.25 | 7.08 |
| 22 Mon Dec | 6.76 | 7.28 | 7.1 |
| 19 Fri Dec | 6.55 | 7.29 | 7.11 |
| 18 Thu Dec | 6.70 | 7.32 | 7.13 |
Myriad Genetics (MYGN) moving average of 100 SMA is at 7.06 and 100 EMA is at 7.07
| Date | Closing Price | 100 SMA | 100 EMA |
| 26 Fri Dec | 6.48 | 7.06 | 7.07 |
| 24 Wed Dec | 6.55 | 7.05 | 7.08 |
| 23 Tue Dec | 6.56 | 7.03 | 7.09 |
| 22 Mon Dec | 6.76 | 7 | 7.1 |
| 19 Fri Dec | 6.55 | 6.97 | 7.11 |
| 18 Thu Dec | 6.70 | 6.95 | 7.12 |
Myriad Genetics (MYGN) moving average of 200 SMA is at 6.6 and 200 EMA is at 8.61
| Date | Closing Price | 200 SMA | 200 EMA |
| 26 Fri Dec | 6.48 | 6.6 | 8.61 |
| 24 Wed Dec | 6.55 | 6.62 | 8.63 |
| 23 Tue Dec | 6.56 | 6.64 | 8.65 |
| 22 Mon Dec | 6.76 | 6.66 | 8.67 |
| 19 Fri Dec | 6.55 | 6.68 | 8.69 |
| 18 Thu Dec | 6.70 | 6.69 | 8.71 |
Takeda Pharmaceutical has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Takeda Pharmaceutical, about 23.6% more returns!
Novo Nordisk has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Novo Nordisk, about 21.27% more returns!
Abbott Laboratories has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Abbott Laboratories, about 11.93% more returns!
Dentsply Sirona has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Dentsply Sirona, about 16.66% more returns!
United Therapeutics has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in United Therapeutics, about 19.42% more returns!
Summit Therapeutics has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Summit Therapeutics, about 16.47% more returns!
Regeneron Pharmaceuticals has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Regeneron Pharmaceuticals, about 15.62% more returns!
Quidel Corporation has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Quidel Corporation, about 22.2% more returns!
Natera Inc has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Natera Inc, about 12.94% more returns!
Orthopediatrics Corp has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Orthopediatrics Corp, about 8.85% more returns!
Kalvista Pharmaceuticals has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Kalvista Pharmaceuticals, about 19.91% more returns!
Icu Medical has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Icu Medical, about 14.69% more returns!
Fulgent Genetics has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Fulgent Genetics, about 5.4% more returns!
Myriad Genetics has performed better than Cue Biopharma in short term. Holding Myriad Genetics could be a better choice for now!
Arvinas Inc has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Arvinas Inc, about 11.65% more returns!
Argenx Se has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Argenx Se, about 7.72% more returns!
Allogene Therapeutics has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Allogene Therapeutics, about 9.59% more returns!
Akebia Therapeutics has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Akebia Therapeutics, about 20.13% more returns!
Achieve Life has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Achieve Life, about 7.27% more returns!
Myriad Genetics Technical analysis of indicators
Price action analysis of Myriad Genetics (MYGN) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Myriad Genetics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Myriad Genetics in short term and the sell signal is strong.
Myriad Genetics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Myriad Genetics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Myriad Genetics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.74 and Myriad Genetics MYGN stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Myriad Genetics MYGN stock. Volume based technical analysis of Myriad Genetics MYGN stock is negative.
Myriad Genetics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock MYGN Myriad Genetics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And MYGN Experts View which covers a lot of information including buying and selling signals
MYGN future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Myriad Genetics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Myriad Genetics (MYGN) Technical (Analysis) Reports Myriad Genetics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
